Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy.
about
Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United kingdom.Pharmaceuticals and personal care products in the environment: what are the big questions?Approaches to the Development of Human Health Toxicity Values for Active Pharmaceutical Ingredients in the EnvironmentDo contaminants originating from state-of-the-art treated wastewater impact the ecological quality of surface waters?Global synthesis and critical evaluation of pharmaceutical data sets collected from river systemsThe environmental side effects of medication.Green pharmacy and pharmEcovigilance: prescribing and the planet.Analysis of the environmental impact of insulin infusion sets based on loss of resources with waste.Potential Upstream Strategies for the Mitigation of Pharmaceuticals in the Aquatic Environment: a Brief Review.Proposal to optimize ecotoxicological evaluation of wastewater treated by conventional biological and ozonation processes.Assessment of Lemna minor (duckweed) and Corbicula fluminea (freshwater clam) as potential indicators of contaminated aquatic ecosystems: responses to presence of psychoactive drug mixtures.International scientists' priorities for research on pharmaceutical and personal care products in the environment.Medications at school: disposing of pharmaceutical waste.Toxicity of individual pharmaceuticals and their mixtures to Aliivibrio fischeri: Experimental results for single compounds and considerations of their mechanisms of action and potential acute effects on aquatic organisms.An ecological perspective on medical care: environmental, occupational, and public health impacts of medical supply and pharmaceutical chains.Mitigating pharmaceutical waste exposures: policy and program considerations.Managing unused pharmaceuticals in a hospice setting: a pilot study.The afterlife of drugs and the role of pharmEcovigilance.Occurrence and fate of micropollutants in the Vidy Bay of Lake Geneva, Switzerland. Part I: priority list for environmental risk assessment of pharmaceuticals.Pharmaceuticals and personal care products (PPCPs) in Arctic environments: indicator contaminants for assessing local and remote anthropogenic sources in a pristine ecosystem in change.Survey of the occurrence of pharmaceuticals in Spanish finished drinking waters.Transcriptional Responses in Adult Zebrafish (Danio rerio) Exposed to Propranolol and Metoprolol.Pharmaceuticals in the environment: an educational perspective.Science and regulation. One Health approach to use of veterinary pharmaceuticals.Toxicity and enantiospecific differences of two β-blockers, propranolol and metoprolol, in the embryos and larvae of zebrafish (Danio rerio).Spatial and Temporal Patterns of Pharmaceuticals in the Aquatic Environment: A ReviewHuman Pharmaceuticals in Wastewater Treatment ProcessesHazardous Components of Household WastePharmaceuticals in Water Systems
P2860
Q24811702-D391D647-32E4-4943-B123-41B406B1C5CFQ26859139-1D87513D-F479-41E1-AEEA-9DDA3C17344CQ28082159-60B9D9D4-D81E-41CA-9910-6EDEDC0ED7F1Q28486081-5D2FD4E2-9560-44A4-B91E-7537DC968E56Q30580997-E67366B4-07EA-4D88-BD37-A0192EBE6B00Q34166413-A83B5217-0B89-4B05-BF49-545966C23EB5Q37960637-0CE6BA0E-2C88-418D-AAAA-4222A93D4D96Q38693462-0101931A-6905-4948-9C0C-4C38D7F3AC25Q38805549-8B1B98CA-CEAC-4B2D-AF9D-40B1DCC43C4FQ38833023-43D81EDE-55D2-4B4C-8053-D953AEA99930Q38987745-711EE0D7-B59B-4C24-AF9F-7121157829E4Q39171782-8812E853-001F-4113-894D-5664546E3CCCQ39199603-48FC52DA-920F-4651-BF8B-B515B5AE4CA5Q39551141-4B552642-AB7A-4E47-83D2-6D1A1F1D90FFQ42255628-639B50BE-4305-4453-9E23-F292D1C22AEEQ42363421-2BEE6502-306D-4AF0-9CB2-B460E910D4ECQ43329060-AEC808AE-5482-47C1-884B-DB38409AACEEQ43366280-8B729357-7E3E-4D02-A1B6-4E0F7489F7D0Q44275877-792492EA-C3E3-4A5E-8362-0DB39E573C77Q46327985-E2936C8D-94A4-4045-B351-F88AC61C68F0Q46357509-4036B6AA-A58D-401B-9BA2-605B59B6C823Q48121953-8CF18792-4851-40C4-AC7D-81BE7F4A51DEQ48539174-D30E1A42-3691-478B-873E-01A992BFB44DQ50443921-92AA6DD9-9A82-4361-AD0C-5506C44B1169Q50745093-FBE139B6-279B-4B95-A3A9-AE863CA27B06Q57238701-CEE9CFF8-0C20-456B-AACF-36584190066CQ57595317-6893DB3D-2923-471F-99F5-50489BB65814Q57595324-3A927231-3C8A-47D6-B030-A6E88ABB2D31Q58867785-2A3D2A51-3E48-42B7-8DFA-51F2BD8199E2
P2860
Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cradle-to-cradle stewardship o ...... venues toward a green pharmacy
@nl
Cradle-to-cradle stewardship o ...... enues toward a green pharmacy.
@ast
Cradle-to-cradle stewardship o ...... enues toward a green pharmacy.
@en
type
label
Cradle-to-cradle stewardship o ...... venues toward a green pharmacy
@nl
Cradle-to-cradle stewardship o ...... enues toward a green pharmacy.
@ast
Cradle-to-cradle stewardship o ...... enues toward a green pharmacy.
@en
prefLabel
Cradle-to-cradle stewardship o ...... venues toward a green pharmacy
@nl
Cradle-to-cradle stewardship o ...... enues toward a green pharmacy.
@ast
Cradle-to-cradle stewardship o ...... enues toward a green pharmacy.
@en
P2860
P921
P356
P1476
Cradle-to-cradle stewardship o ...... enues toward a green pharmacy.
@en
P2093
Christian G Daughton
P2860
P304
P356
10.1289/EHP.5947
P407
P577
2003-05-01T00:00:00Z